The GOOD Guide to Cannabis
Welcome to the golden age of marijuana. Indeed, the future is dope.
- Most Read
FIFA’s new rules say referees can end a game if the crowds can’t stop being racistby Tod Perry
People who were told to 'go back to their country' share their experiences with the racist phraseby May Wilkerson
Christopher Walken dancing in over 50 movies all perfectly spliced into a single music video.by Tod Perry
Dad’s 5-year-old daughter's hilarious answers to his questions have the internet screaming.by Jessie Dean Altman
So few kids know about the Holocaust, Oregon had to pass a law requiring schools to teach about it.by Heidi Lux
After rumors of her death spread online, this distressingly-thin beauty blogger is finally getting help.by Tod Perry
28 Of Barack Obama’s Greatest Achievements As President Of The United Statesby Tod Perry
Tech writer's tweet about Facebook's viral photo challenge is making some people nervous.by Tod Perry
Pornhub’s new environmental campaign means you can now watch adult videos guilt-free.by Tod Perry
Even The Government Wants In On These Trailblazing Marijuana Research Programs
by Tosten Burks
Scientific momentum is so strong in the cannabis industry that even our straight-arrow federal government wants in. While the Drug Enforcement Administration still clings to the claim that the plant has no medical value, the National Institutes of Health funded 49 projects examining the therapeutic properties of cannabinoids last year. The NIH is also ramping up production at the University of Mississippi’s only federally funded marijuana farm, the exclusive supplier for Federal Drug Administration-approved studies. Here are some of the trailblazers to watch:
Multidisciplinary Association for Psychedelic Studies
The California-based nonprofit made history when it announced plans to study cannabis as a treatment for post-traumatic stress disorder in U.S. veterans. Its clinical trial investigating “smoked botanical marijuana” was the first to receive both FDA and DEA approval.
The British company’s natural cannabis-derived mouth spray, Nabiximols, was approved in the United Kingdom in 2010 to treat multiple sclerosis and is offered in 20 countries, excluding the United States. The company is now in late-stage clinical trials for a new cannabidiol-based drug to treat newborns with epilepsy.
University of Minnesota
The NIH gave the university its largest therapeutic cannabinoid-related grant last year—$1.8 million. The study will look at how compounds might prevent pain caused by sickle cell disease.
Scripps Research Institute
Neuroscientists at Scripps received $1.3 million from the NIH to investigate cannabidiol’s potential for treating alcoholism and drug addiction.
The California company is testing a cannabidiol-based drug, APD371, as a general analgesic. Early trials have showed success in treating osteoarthritic and neuropathic pain.